Cereno Scientific AB

Cereno Scientific are active within biotechnology. Today, the company is focused on developing pharmaceuticals for the treatment of various cardiovascular diseases. The products are used to treat potential blood clots that may lead to stroke, myocardial infarction, pulmonary embolism, as well as venous thrombosis. The company was founded in 2012 and is based in Mölndal.

Quotes for Cereno Scientific AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Sten Sörensen

Chairperson of the Board

  • Joakim Söderström

Board

  • Anders Svensson
  • Jonas Faijerson Säljö
  • Lena Mårtensson
  • Sverker Jern
  • Articles of association

    • News

    Show More

    Analysis

    Videos

    Cereno Scientific har haft en intensiv period, många bra nyheter i rad

    VD Sten Sörensen intervjuas av nyhetsbyrån Finwire

    Cereno kommenterar höstens studieresultat #Sitdown

    VD Sten R. Sörensen berättar om bolaget

    Largest Owners

    Name Capital % Votes % Date
    Avanza Pension 17,12 16,73 2024-09-26
    Nordnet Pensionsförsäkring 1,49 1,46 2024-09-26
    Dory Gevryie 1,45 1,42 2024-09-26
    Andreas Ejlegård 1,36 1,33 2024-09-26
    Jan Butt 1,24 1,21 2024-09-26
    Fredrik Frank 1,03 1,01 2024-09-26
    Niklas Borgquist 0,81 0,79 2024-09-26
    Mårten Lundberg 0,79 0,77 2024-09-26
    Sverker Jern 0,77 1,48 2024-09-26
    Andrés Fuentes-Rivera 0,69 0,68 2024-09-26

    Annual reports, prospectus etc.